Error loading player: No playable sources found
2075
Harnessing Multi-Omics Technologies in GI Cancers
Date
May 18, 2024
SOCIETY: AGA
Presentations:
| INCREASED REFLUX SECONDARY BILE ACIDS ARE ASSOCIATED WITH SHIFTS TO THE MICROBIOME AND TRANSCRIPTOME IN BARRETT’S ESOPHAGUS |
| EXPLORING GOBLET CELL-ENRICHED GASTRIC INTESTINAL METAPLASIA (GIM) ORGANOID CULTURE: A PLATFORM FOR THERAPEUTIC DRUG SCREENING |
| TAIWAN CANCER MOONSHOT PROJECT INTERIM REPORT: DECIPHERING DIVERGENT PATHS THROUGH IN-DEPTH COMPARATIVE MULTIOMIC ANALYSIS OF H. PYLORI-ASSOCIATED AND INDEPENDENT GASTRIC CANCER SIGNATURES |
| TRACING PANCREATIC TUMOR EVOLUTION THROUGH SPACE AND TIME |
| SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF SMALL INTESTINAL NEUROENDOCRINE TUMORS REVEALED POTENTIAL MECHANISMS OF MESENTERIC FIBROSIS |
| SINGLE-CELL RNA SEQUENCING IDENTIFIES AGE-RELATED TRANSCRIPTIONAL ALTERATIONS IN EPITHELIAL COLONIC STEM CELLS |
Moderators
Stanford University
University of Pennsylvania
Speakers
Columbia University Medical Center
University of Michigan
General
Tracks
Related Products
AGA Epigenetic Mechanisms Driving GI Cancer
The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence…
